10 news items
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
RYTM
11 Jun 24
. Corporate Contact:David ConnollyHead of Investor Relations and Corporate CommunicationsRhythm
Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024
RYTM
3 Jun 24
:David ConnollyHead of Investor Relations and Corporate CommunicationsRhythm Pharmaceuticals, Inc.857-264-4280
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
RYTM
3 Jun 24
. Corporate Contact:David ConnollyHead of Investor Relations and Corporate CommunicationsRhythm Pharmaceuticals, Inc
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
RYTM
22 May 24
. Corporate Contact:David ConnollyHead of Investor Relations and Corporate CommunicationsRhythm Pharmaceuticals
Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting
RYTM
6 May 24
Head of Investor Relations and Corporate Communications Rhythm Pharmaceuticals, Inc. 857-264-4280
ijnhlqft9qcup0y21kp9sy9022
RYTM
29 Apr 24
. Corporate Contact:David ConnollyHead of Investor Relations and Corporate CommunicationsRhythm
q196gzjsl7d0edeas3zu9n8zawxhrbozk3qbmz92w
RYTM
26 Apr 24
, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once
wo76ofa49l8x1ucth0y a7ri1vw07434l4oj51kdsy27db0xmt5wnmpsup
RYTM
24 Apr 24
Relations and Corporate CommunicationsRhythm Pharmaceuticals, Inc.857-264-4280
ttqt0vv3cqn8jxlc6zwxhqfy42ohzwpf4dbjgzsg9ahzi667gw7qwp nh
RYTM
16 Apr 24
:David ConnollyHead of Investor Relations and Corporate CommunicationsRhythm Pharmaceuticals, Inc.857-264
5qdb9myash8an1sx4o602z6n2fs
RYTM
10 Apr 24
calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts
- Prev
- 1
- Next